Carregant...
Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers
Gastroesophageal (GE) cancers continue to be a significant cause of mortality globally. Despite therapeutic advances in oncology, the prognosis of advanced GE cancer remains exceedingly poor. Immunotherapy has caused a major paradigm shift in the field of oncology. Not all patients benefit from thes...
Guardat en:
| Publicat a: | J Gastrointest Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848035/ https://ncbi.nlm.nih.gov/pubmed/29564185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.12 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|